GRWD1 Inhibitors
GRWD1 inhibitors represent a class of chemical compounds designed to specifically target and modulate the activity of the GRWD1 protein, also known as Glutamate-Rich WD40 Repeat Containing 1. GRWD1 is a scaffolding protein characterized by its WD40 repeat motifs, which are involved in a wide variety of protein-protein interactions. These interactions facilitate the assembly of protein complexes, particularly those related to chromatin remodeling and ribosome biogenesis. By inhibiting GRWD1, these compounds interfere with the formation and stabilization of such complexes, which can have a downstream effect on cellular processes such as gene expression regulation, chromosomal maintenance, and protein synthesis. Inhibition of GRWD1 is also known to affect cell cycle progression, particularly the transitions between phases, as the protein is involved in the regulation of several key molecular pathways that ensure the accurate replication and segregation of DNA.
At the molecular level, GRWD1 inhibitors often exhibit high specificity, targeting the structural domains of the GRWD1 protein, including its WD40 repeats, which are essential for its interaction with other proteins. These inhibitors may also exploit allosteric sites to modulate the protein's conformational flexibility, thus hindering its biological functions. The development and characterization of these inhibitors have highlighted their role in modulating key cellular functions, particularly in the context of DNA replication stress and cellular growth control. Importantly, GRWD1 inhibitors provide insight into how structural perturbations in chromatin organization and ribosome biogenesis can lead to altered cellular states. Studying these inhibitors not only helps elucidate the intricate role of GRWD1 in fundamental biological processes but also deepens our understanding of how protein-protein interaction networks influence cellular homeostasis and genomic integrity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis at the translocation step on the ribosome, effectively reducing the overall pool of new proteins, including GRWD1. This depletion affects cellular protein homeostasis and can indirectly lead to a reduction in GRWD1 levels, thus inhibiting its functional activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132, a proteasome inhibitor, blocks the degradation of polyubiquitinated proteins, potentially causing an accumulation of proteins that compete with or regulate GRWD1, leading to its functional inhibition due to altered protein interactions and cellular stress responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 suppresses the AKT pathway, which is involved in various cellular functions, including protein synthesis and degradation. The suppression of this pathway can indirectly destabilize GRWD1 or affect its regulatory mechanisms, leading to a decrease in its functional activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine broadly inhibits protein kinases, potentially affecting the phosphorylation state of GRWD1 or proteins that interact with or regulate GRWD1. This can lead to an indirect inhibition of GRWD1's function due to the disruption of essential phosphorylation-dependent cellular signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR, rapamycin reduces protein synthesis, which could lead to a lower level of GRWD1 and its associated activities. The inhibition of mTOR signaling affects many cellular processes, possibly leading to a decrease in GRWD1's functional presence due to diminished synthesis and affected turnover. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
This compound disrupts RNA synthesis, which could indirectly inhibit GRWD1 by affecting the ribonucleoprotein complexes that GRWD1 is associated with, thereby potentially impairing its function in the processing and assembly of these complexes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an HDAC inhibitor, Trichostatin A alters acetylation patterns on histones, affecting gene expression globally. This could lead to changes in the cellular levels or interactions of GRWD1, thus indirectly inhibiting its function through the alteration of chromatin structure and gene expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, similar to MG-132, inhibits the proteasome pathway, potentially causing a buildup of proteins that can indirectly inhibit GRWD1 by altering its native interactions and leading to cellular stress responses, which may affect GRWD1's stability and function. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
This compound binds to Hsp90, inhibiting its chaperone activity. Hsp90 is involved in stabilizing many proteins; thus, inhibiting Hsp90 could destabilize GRWD1, either directly or indirectly, by affecting the proteins that regulate or interact with GRWD1, leading to a decrease in its functional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, impacting the MAPK signaling pathway. This can indirectly inhibit GRWD1 by altering downstream signaling events and transcription factors that regulate the cellular environment and processes in which GRWD1 functions, potentially leading to its functional inhibition. | ||||||